Reprogenix: Funding, Investors & Team (Sep 2026)
Reprogenix is a groundbreaking medical technology firm
Reprogenix has raised $70.3M across 1 funding round on record, the most recent a Series A of $70.3M announced in Nov 2025.
That round is above the $12M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Reprogenix Company Profile and Key Stats
Latest funding round on record: Nov 2025.
Reprogenix Funding Rounds
Reprogenix Founders and Leadership Team
No contact details are on record for this team yet.
Reprogenix Funding Compared to Other Biotechnology Startups
Reprogenix's latest round of $70.3M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Reprogenix in Biotechnology and Hangzhou
Companies Similar to Reprogenix
GRIT Biotechnology develops tumor infiltration lymphocytes immunotherapy for solid tumors.
Expedition Therapeutics is a biotechnology company that develops novel therapies for inflammatory and…
Captain T Cell is a start-up project that develops T cell-based immunotherapies for cancer patients.
Rion Vet mission is to drive the regenerative medicine revolution.
Oncolab is developing a technology that reduces systemic toxicity and enhances therapeutic efficacy.
Modulight Bio develops an optogenetic platform intended for the treatment of neurological disorders.
Nomax Therapeutics develops a healthcare technology platform to provide therapies for neurodegenerative…
Gregor Diagnostics is a molecular diagnostics company developing a screening test technology for prostate…
Gut Brain Axis Therapeutics is a biotechnology company that offers treatment for Autism Spectrum Disorder…
AAVantgarde Bio is a clinical-stage biotechnology company that develops gene therapies for inherited retinal…
iOrganBio is a pioneering cell production platform.
BlueWhale Bio is committed to advancing cell-based therapeutics through manufacturing innovation.
Reprogenix Funding FAQs
What does Reprogenix do?
Reprogenix is a groundbreaking medical technology firm
How much funding has Reprogenix raised?
Reprogenix has raised $70.3M across 1 round on record. The most recent is a Series A of $70.3M announced in Nov 2025.
When did Reprogenix last raise funding?
Reprogenix's most recent funding round on record is a Series A of $70.3M, announced in Nov 2025.
Where is Reprogenix headquartered?
Reprogenix is based in Hangzhou, China.
How does Reprogenix's funding compare to other Biotechnology startups?
Reprogenix's latest round of $70.3M is above the $12M median round size for Biotechnology companies on FundedIQ across 27 tracked companies over the last two years.
About FundedIQ's Reprogenix Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Reprogenix is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.